0000950170-23-065545.txt : 20231121
0000950170-23-065545.hdr.sgml : 20231121
20231121164312
ACCESSION NUMBER: 0000950170-23-065545
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231121
DATE AS OF CHANGE: 20231121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WINDSOR JAMES BRIAN
CENTRAL INDEX KEY: 0001790933
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 231428828
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 738 MAIN STREET
STREET 2: UNIT 398
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 738 MAIN STREET
STREET 2: UNIT 398
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
ownership.xml
4
X0508
4
2023-11-20
0001420565
AILERON THERAPEUTICS INC
ALRN
0001790933
WINDSOR JAMES BRIAN
C/O AILERON THERAPEUTICS, INC.
738 MAIN STREET #398
WALTHAM
MA
02451
false
true
false
false
President and COO
false
Common Stock
2023-11-20
4
P
false
5076
1.9675
A
5122
D
This transaction was executed in multiple trades at prices ranging from $1.965 - $1.9699. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ James Brian Windsor
2023-11-21